Media Summary: Dr Lee speaks with ecancer at WIN 2017 about changing attitudes and designs of In this episode of "In the Interim…", Dr. Scott Berry is joined by Dr. Will Meurer, professor of Emergency Medicine and Neurology at ... A presentation from the Science on the Swan Conference 2021. Chair: Susan Rumisha Speaker: Professor Steve Webb (Monash ...

Charles Green Bayesian Adaptive Trial Designs - Detailed Analysis & Overview

Dr Lee speaks with ecancer at WIN 2017 about changing attitudes and designs of In this episode of "In the Interim…", Dr. Scott Berry is joined by Dr. Will Meurer, professor of Emergency Medicine and Neurology at ... A presentation from the Science on the Swan Conference 2021. Chair: Susan Rumisha Speaker: Professor Steve Webb (Monash ... The 2014 East User Group Meeting's invited speaker presentations: Satrajit Roychoudhury, from Novartis, reveals lessons ... Presentation Title: A Perspective Review of FDA's Draft Guidance on the Use of In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele deliver a quick reaction to the FDA's draft guidance on ...

Suyu Liu, PhD is Associate Professor, Department of Biostatistics at The University of Texas MD Anderson Cancer Center.

Photo Gallery

Charles Green:  Bayesian Adaptive Trial Designs
Bayesian adaptive trial designs for precision medicine
Webinar:  Bayesian Outcome Adaptive Randomization Trial Designs  A Promise Not Without Perils
ICECAP: The Adaptive Design
Adaptive Trial Designs - Alex Kaizer @  ERD Conference 6.5.19
REMAP-CAP: A Bayesian Adaptive Trial Identifying Treatments for COVID-19
A Bayesian Industry Approach to Phase 1 Combination Trials in Oncology - Satrajit Roychoudhury
A Perspective Review of FDA's Draft Guidance on the Use of Bayesian Methodology in Clinical Trials
Group Sequential Designs:  Introduction to Adaptive Trial Designs using FACTS
Bayesian analysis in adaptive trials
The FDA Bayesian Guidance
How to design an adaptive platform trial
Sponsored
View Detailed Profile
Charles Green:  Bayesian Adaptive Trial Designs

Charles Green: Bayesian Adaptive Trial Designs

... was a

Bayesian adaptive trial designs for precision medicine

Bayesian adaptive trial designs for precision medicine

Dr Lee speaks with ecancer at WIN 2017 about changing attitudes and designs of

Webinar:  Bayesian Outcome Adaptive Randomization Trial Designs  A Promise Not Without Perils

Webinar: Bayesian Outcome Adaptive Randomization Trial Designs A Promise Not Without Perils

Webinar on

ICECAP: The Adaptive Design

ICECAP: The Adaptive Design

In this episode of "In the Interim…", Dr. Scott Berry is joined by Dr. Will Meurer, professor of Emergency Medicine and Neurology at ...

Adaptive Trial Designs - Alex Kaizer @  ERD Conference 6.5.19

Adaptive Trial Designs - Alex Kaizer @ ERD Conference 6.5.19

Adaptive

Sponsored
REMAP-CAP: A Bayesian Adaptive Trial Identifying Treatments for COVID-19

REMAP-CAP: A Bayesian Adaptive Trial Identifying Treatments for COVID-19

A presentation from the Science on the Swan Conference 2021. Chair: Susan Rumisha Speaker: Professor Steve Webb (Monash ...

A Bayesian Industry Approach to Phase 1 Combination Trials in Oncology - Satrajit Roychoudhury

A Bayesian Industry Approach to Phase 1 Combination Trials in Oncology - Satrajit Roychoudhury

The 2014 East User Group Meeting's invited speaker presentations: Satrajit Roychoudhury, from Novartis, reveals lessons ...

A Perspective Review of FDA's Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

A Perspective Review of FDA's Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

Presentation Title: A Perspective Review of FDA's Draft Guidance on the Use of

Group Sequential Designs:  Introduction to Adaptive Trial Designs using FACTS

Group Sequential Designs: Introduction to Adaptive Trial Designs using FACTS

In this video we look at

Bayesian analysis in adaptive trials

Bayesian analysis in adaptive trials

Adaptive

The FDA Bayesian Guidance

The FDA Bayesian Guidance

In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele deliver a quick reaction to the FDA's draft guidance on ...

How to design an adaptive platform trial

How to design an adaptive platform trial

Dr. Ben Saville speaks about how to

Suyu Liu, PhD - A Bayesian Phase I/II Trial Design for Immunotherapy

Suyu Liu, PhD - A Bayesian Phase I/II Trial Design for Immunotherapy

Suyu Liu, PhD is Associate Professor, Department of Biostatistics at The University of Texas MD Anderson Cancer Center.